🇨🇦 BNT162b2 (Omi JN.1) in Canada

BNT162b2 (Omi JN.1) (bnt162b2-omi-jn-1) regulatory status in Canada.

Marketing authorisation

BNT162b2 (Omi JN.1) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Canada

Frequently asked questions

Is BNT162b2 (Omi JN.1) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for BNT162b2 (Omi JN.1) in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.